Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Specimen Handling 258 Magnetic Resonance Spectroscopy 213 pembrolizumab 202 Carboplatin 170 Cisplatin 137 Biopsy 133 Cyclophosphamide 130 Paclitaxel 120 Nivolumab 109 Gemcitabine 102 Bevacizumab 102 Radiotherapy 81 Dexamethasone 77 Pemetrexed 75 atezolizumab 71 Fluorouracil 71 fludarabine 68 Doxorubicin 67 Leucovorin 66 Docetaxel 65 Radiation 64 Oxaliplatin 62 Rituximab 60 venetoclax 58 Prednisone 57 Cetuximab 54 durvalumab 53 Vincristine 52 Etoposide 51 130-nm albumin-bound paclitaxel 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Triiodothyronine × 30 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡